Costa Mesa Medicaid COVID-19 claims reach $780,110 in 2024

Dr. Mehmet Oz CMS Administrator
Dr. Mehmet Oz CMS Administrator
0Comments

At least $780,110 in Medicaid payments were made in Costa Mesa for services officially coded as COVID-19 related in 2024, based on data from the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid is a state-administered public health insurance program funded jointly by state and federal governments. The program serves low-income residents, children, seniors, and people with disabilities, representing one of the largest portions of the American health care landscape.

Because taxpayer contributions fund Medicaid, fluctuations in billing reflect how community health care resources are distributed.

Researchers classified COVID-19–related services by identifying HCPCS codes with billing descriptions or reference data identifying them as “COVID-19” or “coronavirus.” Consequently, this analysis accounts for only those services directly flagged as COVID-related in billing data and may not include care connected to the pandemic billed under other codes.

For comparison, San Jose reported the most Medicaid COVID-19 service payments among California communities in 2024, with $5,601,479 in claims related to the virus.

In Costa Mesa, two providers billed Medicaid for COVID-19–related services in 2024. The most frequently billed code was COVID Specific, with a total of $767,151.

On average, Costa Mesa Medicaid providers received $390,055 each for COVID-19–related services in 2024, compared with the state average of $52,976.

COVID-19–specific claims contributed to only a small portion of the rise in Costa Mesa’s Medicaid spending during the pandemic years.

All other claim categories combined saw total Medicaid payments increase by $63,870,513 between 2020 and 2024, or a gain of 347%.

In the two years before the pandemic, annual Medicaid payments in Costa Mesa averaged $16,114,904.

According to the Centers for Medicare & Medicaid Services, combined federal and state Medicaid spending was nearly $871.7 billion in fiscal year 2023, comprising about 18% of the country’s total health spending. That marks a substantial increase from roughly $613.5 billion in 2019, before the COVID-19 pandemic.

The growth represents an increase of approximately 40% over several years, mostly attributed to expanded enrollment and higher usage during and after the pandemic period.

Recent federal legislation introduced under the Trump administration included notable proposals to decrease the federal share of Medicaid funding and overhaul the structure of the program. For instance, the “One Big Beautiful Bill Act,” enacted in 2025, is expected to reduce federal Medicaid spending by more than $1 trillion over the next decade. New policies, such as work requirements and increased cost-sharing, could restrict access and funding for some recipients. These adjustments are projected to place more responsibility on states and curb federal Medicaid growth, even as the program continues to provide coverage for tens of millions nationwide.

Medicaid Payments in Costa Mesa Over 7 Years
Year COVID-19–Related Payments COVID-19 Payments % Change (YoY) Total Medicaid Payments
2024 $780,110 -14.3% $83,056,533
2023 $910,008 5.8% $50,142,658
2022 $859,843 1,247% $22,270,587
2021 $63,835 12,268.3% $24,167,546
2020 $516 N/A $18,406,427
2019 $0 N/A $17,201,772
2018 $0 N/A $15,028,035
Top COVID-19–Related HCPCS Codes in Costa Mesa
HCPCS Code Description Medicaid Payments Claims
87635 COVID Specific $767,151 17,714
87811 Immunoassay $12,959 376

Note: Data includes only HCPCS codes explicitly identified as COVID-19 services. Figures do not represent all spending linked to the pandemic.

Information for this report was sourced from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The original data is available here.



Related

Dave Min, U.S. Representative of California's 47th Congressional District

House bill proposes mandatory harassment reporting programs for major transit agencies

Rep. Dave Min introduced a bill in the House aimed at strengthening passenger harassment reporting procedures and data collection within public transit systems, seeking to address and better track incidents.

Jim Traficant, Chief of Staff of FDA

FDA cites Boscogen, Inc. in Irvine for 4 violations during April 21 inspection

The Food and Drug Administration inspected Boscogen, Inc. in Irvine on April 21, issuing four citations related to food composition, standards, labeling and econ, according to the FDA’s official website.

Sara Brenner, Principal Deputy Commissioner at FDA

FDA reviews Fina International, Inc. in Tustin during April 28 inspection

On April 28, the FDA conducted a foodborne biological hazard inspection at Fina International, Inc. in Tustin, according to information on the agency’s website.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Central OC Times.